Short answer: pooled clinical trials suggest green tea is associated with a small drop in blood pressure, on the order of about 1 mmHg systolic and 1 mmHg diastolic in the largest and most recent analysis. That's a real signal, but it's modest, the trials disagree with each other a lot, and here's the part almost nobody says out loud: no clinical trial has ever tested matcha specifically with blood pressure as an outcome. Every matcha blood pressure claim you've read, including any you might expect from a matcha company, is borrowed from studies of brewed green tea and green tea extract capsules.
Key Takeaways
- The honest number is about 1 mmHg. The newest pooled analysis of 36 randomised trials found green tea supplementation reduced systolic blood pressure by 1.08 mmHg and diastolic by 1.09 mmHg (Rezaei 2025, Blood Pressure).
- The effect has shrunk as the evidence has grown. Early reviews built on a handful of small trials reported around 3 mmHg. As the trial count rose from 7 to 36, the pooled estimate roughly halved.
- Matcha itself is untested here. Human matcha trials exist, but they measured cognition, sleep, brown fat and gum health. A search of the ClinicalTrials.gov registry returns no matcha trial listing blood pressure as an outcome.
- Matcha contains caffeine, and caffeine raises blood pressure acutely. A normal 2 g bowl carries roughly 40 to 70 mg, well under the 200 to 300 mg doses that produced a measurable rise in trials.
- If you take a beta blocker, this matters more than any benefit here. Green tea cut plasma levels of the beta blocker nadolol by around 85% in a controlled study. Talk to your doctor.
What blood pressure actually measures
Two numbers, one fraction. The top number, systolic, is the pressure in your arteries when the heart contracts. The bottom number, diastolic, is the pressure between beats, when the heart is refilling. Both are measured in millimetres of mercury, written mmHg.
That unit matters for reading everything below. When a study reports a 1 mmHg change, it's describing a shift so small you'd never feel it, and one that sits inside the range a single cuff reading can vary by depending on whether you're talking, sitting badly, or slightly stressed. Small effects across a whole population can still be meaningful. Small effects for one person on one afternoon usually aren't.
The matcha connection: catechins, EGCG, and L-theanine
Matcha is shade grown, stone ground, and consumed as whole leaf suspended in water rather than as an infusion you strain and discard. Whole-leaf consumption is the only compositional claim about matcha I'd defend strongly, and it's worth being precise about why.
Analytical chemists measured 15 commercial green teas, including 10 matcha samples, and published a full per-sample catechin table (Meyer 2023, Plant Foods for Human Nutrition). Here's what a gram of matcha actually holds:
| Compound | Per gram of matcha | Per 2 g bowl |
|---|---|---|
| EGCG | ~35 to 70 mg | ~70 to 140 mg |
| Total catechins | ~80 to 130 mg | ~160 to 260 mg |
| Caffeine | ~20 to 40 mg | ~40 to 80 mg |
| L-theanine | ~5 to 30 mg | ~10 to 60 mg |
Ranges from Meyer 2023 and Unno 2018, Nutrients. Total catechins are summed from the published per-compound values.
In that same Meyer analysis, the per-gram differences between matcha and ordinary bagged green tea were not statistically significant. Ceremonial matcha averaged 56.6 mg/g of EGCG, bagged and gunpowder green teas averaged 46.1 mg/g, and the gap didn't clear the bar. That's an uncomfortable finding for a matcha company to publish, and I'd rather you hear it from us. The researchers also found the cheaper culinary matcha carried higher total phenolic content than ceremonial. Matcha's real advantage isn't that the leaf is richer. It's that you swallow the leaf instead of throwing it away.
The claim that matcha has 137 times the antioxidants of green tea traces to a single 2003 chromatography paper (Weiss and Anderton, Journal of Chromatography A), and it's been mangled twice over. It was EGCG, not antioxidants generally. And the comparison was against one named commercial product, not green tea as a category. The same abstract gives the class-level figure: at least three times. A later experiment measured roughly a threefold increase in extracted EGCG from powdered versus leaf tea under controlled brewing (Fujioka 2016, Molecules). Three, not 137. For more on the compound itself, see our guide to what EGCG is in green tea.
What the research actually shows
Six pooled analyses of randomised trials have looked at green tea and blood pressure since 2013. They agree on direction and disagree on nearly everything else. The same pattern shows up in the cholesterol literature, where the effect is real, small, and easy to oversell.
| Meta-analysis | Trials | Systolic, mmHg (95% CI) | Diastolic, mmHg (95% CI) |
|---|---|---|---|
| Hartley 2013, Cochrane | 7 green tea (of 11, n=821) | -3.18 (-5.25, -1.11) | -3.42 (-4.54, -2.30) |
| Khalesi 2014, Eur J Nutr | 13 | -2.08 (-3.06, -1.05) | -1.71 (-2.86, -0.56) |
| Peng 2014, Sci Rep | 13 (n=1,367) | -1.98 (-2.94, -1.01) | -1.92 (-3.17, -0.68) |
| Onakpoya 2014, Nutr Metab Cardiovasc Dis | 20 (n=1,536) | -1.94 (-2.95, -0.93) | Not significant |
| Xu 2020, Medicine | 24 (n=1,697) | -1.17 (-2.18, -0.16) | -1.24 (-2.07, -0.40) |
| Rezaei 2025, Blood Pressure | 36 | -1.08 (-1.98, -0.18) | -1.09 (-1.67, -0.50) |
Rezaei and colleagues pooled 36 randomised trials and found green tea supplementation reduced systolic pressure by 1.08 mmHg and diastolic by 1.09 mmHg (Rezaei 2025). Their own conclusion is appropriately cool: green tea "is better considered a complementary approach for managing blood pressure."
The uncertainty here is not a footnote. That analysis reported I² of 85% for systolic, meaning the great majority of the variation between trials isn't explained by chance. When trials scatter that widely, a pooled average is a weak summary of a messy picture. The authors also found no clear relationship between the dose of tea and the change in blood pressure, which is exactly what you would not expect if the effect were straightforwardly causal.
Older reviews reported larger effects on thinner evidence. The 2013 Cochrane review found 3.18 mmHg systolic and 3.42 diastolic for green tea, and it's the figure most often quoted online (Hartley 2013, Cochrane Database of Systematic Reviews). But those numbers rest on seven small trials, and the review says plainly that the green tea results "were not stable to sensitivity analysis." Cochrane also recorded something that should temper the whole conversation: no study reported cardiovascular events. Every finding in this article is a surrogate marker on a cuff, not a demonstration that anyone avoided anything.
And the positive results aren't unanimous. A 2025 analysis in people with metabolic syndrome found no significant effect on either systolic or diastolic pressure (Ghoflchi 2025, Clinical Therapeutics). A meta-analysis of 14 tea trials in 798 people over 4 to 24 weeks also found nothing significant for blood pressure or lipids (Igho-Osagie 2020, Journal of Nutrition).
One consistent pattern: starting point seems to matter
The most repeated finding across these analyses is that the effect appears larger in people whose blood pressure was already elevated. Khalesi found greater reductions where baseline systolic was 130 mmHg or above (Khalesi 2014, European Journal of Nutrition, 13 trials, systolic -2.08 mmHg). Rezaei found stronger effects above 120 mmHg. A separate review in prehypertensive and hypertensive people found -2.36 systolic across 10 trials in 834 participants (Yarmolinsky 2015, Nutrition Reviews), though that one pooled green and black tea together.
That subgroup pattern is worth holding lightly. Groups with higher starting values have more room to fall, and they tend to drift downward on repeat measurement regardless of what you give them. That's regression to the mean, and it produces exactly this pattern. Subgroup findings raise hypotheses. They don't settle them.
Matcha, caffeine, and short-term blood pressure
An article about matcha and blood pressure that skips caffeine isn't being straight with you. Matcha contains a meaningful dose, and caffeine has a well-characterised short-term pressor effect.
Pooled acute trials in people with high blood pressure found that 200 to 300 mg of caffeine raised systolic pressure by 8.1 mmHg and diastolic by 5.7 mmHg, appearing in the first hour and lasting three hours or more (Mesas 2011, American Journal of Clinical Nutrition). Note that this acute effect is several times larger than the catechin effect running the other way.
Scale matters, though. At roughly 30 mg of caffeine per gram, a 200 to 300 mg dose means 7 to 10 grams of matcha in one sitting, which is three to five full bowls back to back. A single 2 g bowl sits at 40 to 80 mg, comfortably below the doses that moved the needle in these trials.
Over weeks rather than hours, the picture changes again, and the delivery vehicle seems to matter more than the molecule. Pooling 16 trials in 1,010 people, isolated caffeine at a median 410 mg/day raised systolic pressure by 4.16 mmHg, while the same compound delivered as coffee raised it by only 1.22 mmHg, with the diastolic effect not reaching significance (Noordzij 2005, Journal of Hypertension). Mesas also noted that in three studies of coffee lasting two weeks, no increase in blood pressure was observed at all.
One study deserves credit for finding the opposite of what it expected. Researchers gave 20 men tea or caffeine-matched water and measured them at 30 minutes, testing the popular idea that L-theanine and flavonoids blunt caffeine's pressor effect. Tea produced larger acute rises than caffeine alone. For green tea specifically the increase was 5.5 mmHg systolic, but the confidence interval ran from -1.4 to 12.4, so it didn't reach statistical significance. Black tea's 10.7 mmHg did. Then, in a second experiment, five cups a day for seven days produced no significant change in 24-hour ambulatory blood pressure (Hodgson 1999, Journal of Hypertension). So the tidy story that theanine cancels caffeine isn't supported. What the data suggest instead is that the acute bump, whatever its size, doesn't persist into daily life. If you want the fuller comparison, see matcha versus green tea caffeine.
No trial has tested matcha for blood pressure
There is no human trial of matcha with blood pressure as an outcome. Not a weak one. None. This is the part I most want on the record, because it's the thing our own industry is quietest about.
Searches of the published literature return nothing, and a query of the ClinicalTrials.gov registry for matcha interventions returned 9 registered studies on 14 August 2026, none of which lists blood pressure, systolic, diastolic, or hypertension among its conditions or outcomes.
Human matcha trials do exist, and they're interesting. They just looked elsewhere:
| Matcha trial | What it measured | Blood pressure? |
|---|---|---|
| Uchida 2024, PLoS One (12-month RCT) | Cognition, sleep quality, emotional perception | No |
| El-Elimat 2022, Plant Foods Hum Nutr (non-randomised, 40 enrolled) | Body measures, fasting glucose, HbA1c, lipids | No |
| Taniguchi 2026, Physiological Reports (crossover, n=30) | Brown adipose tissue activity | No |
| Abood 2025, Oral Health Prev Dent (pilot, n=27) | Plaque and gum inflammation markers | No |
So the chain of reasoning behind every matcha blood pressure claim goes: green tea extract capsules showed a small effect, matcha contains similar compounds, therefore matcha. That's an inference, not a finding. And it's a shakier inference than it looks, because matcha delivers those compounds differently from both the capsules and the infusions that were actually studied. Whether that difference helps, hurts, or does nothing has not been measured.
I'd rather sell you tea and tell you that than round the gap up into a benefit. For the bigger picture, see our guide to the research-backed benefits of matcha.
How much matcha, realistically
If you want to align a daily practice with what the trials used, one to two 2 g servings a day is the honest reading, taken consistently over weeks rather than days. The trials pooled above ran from a few weeks to several months, and Xu 2020 describes its own evidence base as short-term throughout. That lands you around 70 to 280 mg of EGCG daily and 40 to 160 mg of caffeine.
A few practical notes:
- Consistency over intensity. The trials ran for weeks and months. Nothing here responds to a big weekend.
- Don't chase the dose. Rezaei 2025 found no clear relationship between green tea dose and blood pressure change across 36 trials, and in their subgroups the effect was actually stronger below 500 mg/day. More is not better here.
- Watch the sugar. A sweetened matcha latte brings its own metabolic baggage. Whisk into water or unsweetened milk.
- Skip high-dose extracts. Concentrated green tea extract supplements are a different product with a different risk profile from a bowl of whisked tea.
Individual response varies. Consult your doctor before changing your routine if you manage a condition.
On the daily rhythm side, we've written separately about whether you can drink matcha every day.
What matcha is not
Matcha is not a blood pressure treatment, and it is not a substitute for medication, monitoring, or your doctor's advice. A 1 mmHg average shift across a population is not a therapy.
There's one specific risk worth more of your attention than any benefit on this page. In a controlled study, drinking 700 mL of green tea daily for 14 days reduced peak plasma concentrations of the beta blocker nadolol by 85.3% and total drug exposure by 85.0%, and the drug's effect on systolic blood pressure was significantly reduced (Misaka 2014, Clinical Pharmacology and Therapeutics). The likely mechanism is green tea blocking an intestinal transporter the drug needs for absorption. Nadolol is prescribed for blood pressure. If you take a beta blocker, raise green tea and matcha with your doctor or pharmacist before making it a daily habit.
It's also worth knowing that green tea isn't uniformly benign in trial data. The Oxford review of 20 trials in 1,536 participants listed adverse events including rash, abdominal discomfort, and elevated blood pressure (Onakpoya 2014, Nutrition, Metabolism and Cardiovascular Diseases).
The honest framing is the same one we use for matcha and cholesterol and matcha and blood sugar. A daily bowl is one small, pleasant thing among many, sitting alongside sleep, movement, salt, and whatever your doctor recommends. Its best documented effect is the one no trial is measuring: a few quiet minutes where you whisk something with your hands and pay attention to it.
May you become one with tea, one with yourself.
If you'd like to make it a daily practice, our USDA Organic Ceremonial Matcha (30g) is stone ground, first harvest, and sourced directly from named Japanese growers. For cafés and retailers, our wholesale program is open.
Frequently asked questions
Does matcha lower blood pressure?
No trial has tested matcha specifically for this. In pooled randomised trials of green tea, supplementation was associated with a reduction of about 1.08 mmHg systolic and 1.09 mmHg diastolic (Rezaei 2025, 36 trials). The effect is small, the trials vary widely, and applying it to matcha is an extrapolation rather than a measured result.
Can matcha raise blood pressure because of the caffeine?
Acutely, caffeine can. Doses of 200 to 300 mg raised systolic pressure by around 8 mmHg for three hours or more in people with high blood pressure (Mesas 2011). A 2 g bowl of matcha contains roughly 40 to 80 mg, so reaching that dose would take three to five bowls in quick succession. Over weeks of regular tea drinking, ambulatory blood pressure showed no significant change (Hodgson 1999).
How much matcha would match the amounts used in studies?
Roughly one to two 2 g servings daily, taken consistently over weeks. That's about 70 to 280 mg of EGCG. Higher doses don't appear to help, and the newest analysis found no clear dose-response relationship.
Can matcha replace my blood pressure medication?
No. Matcha is a food, and its measured effect is a fraction of what medication does. It should never replace a prescription. Green tea can also interfere with some blood pressure drugs, notably the beta blocker nadolol, so talk to your doctor before making it a daily habit.
Is ceremonial grade matcha better than culinary for blood pressure?
Not measurably. Analysis of 10 matcha samples found ceremonial averaged more EGCG than culinary, but the difference was not statistically significant, and culinary matcha actually carried higher total phenolic content (Meyer 2023). Choose ceremonial for taste and texture, not for chemistry.
More in the matcha science series: What is EGCG · Matcha and cholesterol · Matcha and blood sugar · Matcha and cortisol · What is L-theanine
Share:
Matcha and Anxiety: What the L-Theanine Trials Actually Found
Yabukita: The Tea Cultivar Behind Most Japanese Green Tea